Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

EMT transcription factors snail and slug directly contribute to cisplatin resistance in ovarian cancer

  • Alexandria M Haslehurst1,
  • Madhuri Koti1,
  • Moyez Dharsee4,
  • Paulo Nuin1, 4,
  • Ken Evans1, 4,
  • Joseph Geraci4,
  • Timothy Childs1,
  • Jian Chen4,
  • Jieran Li4,
  • Johanne Weberpals2,
  • Scott Davey1,
  • Jeremy Squire1, 3,
  • Paul C Park1 and
  • Harriet Feilotter1, 4Email author
BMC Cancer201212:91

DOI: 10.1186/1471-2407-12-91

Received: 13 December 2011

Accepted: 19 March 2012

Published: 19 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
13 Dec 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
7 Jan 2012 Reviewed Reviewer Report - Martin Koebel
16 Jan 2012 Reviewed Reviewer Report - Alice Wong
6 Feb 2012 Author responded Author comments - Harriet Feilotter
Resubmission - Version 3
6 Feb 2012 Submitted Manuscript version 3
14 Feb 2012 Reviewed Reviewer Report - Martin Koebel
14 Feb 2012 Reviewed Reviewer Report - Alice Wong
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
19 Mar 2012 Editorially accepted
19 Mar 2012 Article published 10.1186/1471-2407-12-91

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Pathology and Molecular Medicine, Queen's University
(2)
Division of Gynaecologic Oncology, The Ottawa Hospital
(3)
NCIC Clinical Trials Group, Cancer Research Institute
(4)
Ontario Cancer Biomarker Network

Advertisement